ROQAF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
Capitalization
3.45M
SNTI
Price
$3.67
Change
+$0.39 (+11.89%)
Updated
Apr 15, 04:59 PM (EDT)
Capitalization
95.44M
Ad is loading...

ROQAF vs SNTI

Header iconROQAF vs SNTI Comparison
Open Charts ROQAF vs SNTIBanner chart's image
Roquefort Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$600
Capitalization3.45M
Senti Biosciences
Price$3.67
Change+$0.39 (+11.89%)
Volume$128
Capitalization95.44M
ROQAF vs SNTI Comparison Chart
Loading...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ROQAF vs. SNTI commentary
Apr 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROQAF is a Buy and SNTI is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 16, 2025
Stock price -- (ROQAF: $0.05 vs. SNTI: $3.28)
Brand notoriety: ROQAF and SNTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROQAF: 100% vs. SNTI: 111%
Market capitalization -- ROQAF: $3.65M vs. SNTI: $84.77M
ROQAF [@Biotechnology] is valued at $3.65M. SNTI’s [@Biotechnology] market capitalization is $84.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $281.29B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROQAF’s FA Score shows that 1 FA rating(s) are green whileSNTI’s FA Score has 0 green FA rating(s).

  • ROQAF’s FA Score: 1 green, 4 red.
  • SNTI’s FA Score: 0 green, 5 red.
According to our system of comparison, SNTI is a better buy in the long-term than ROQAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNTI’s TA Score shows that 4 TA indicator(s) are bullish.

  • SNTI’s TA Score: 4 bullish, 3 bearish.

Price Growth

ROQAF (@Biotechnology) experienced а 0.00% price change this week, while SNTI (@Biotechnology) price change was +10.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.86%. For the same industry, the average monthly price growth was -13.47%, and the average quarterly price growth was -21.42%.

Reported Earning Dates

SNTI is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (+8.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNTI($95.4M) has a higher market cap than ROQAF($3.45M). ROQAF YTD gains are higher at: 0.000 vs. SNTI (-6.553).
ROQAFSNTIROQAF / SNTI
Capitalization3.45M95.4M4%
EBITDAN/A-57.12M-
Gain YTD0.000-6.553-
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A10.5M-
Total DebtN/A34.7M-
TECHNICAL ANALYSIS
Technical Analysis
SNTI
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 7 days ago
79%
View a ticker or compare two or three
Ad is loading...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTAIY6.000.49
+8.79%
PT Astra International
NTDOF74.424.96
+7.14%
Nintendo Co., Ltd.
KKOYY11.030.32
+2.99%
Kesko OY
ARREF1.260.03
+2.44%
Amerigo Resources Ltd.
CVSI0.03N/A
-3.23%
CV Sciences, Inc.

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
GNTA - ROQAF
36%
Loosely correlated
+3.84%
CRBP - ROQAF
22%
Poorly correlated
-3.97%
SVRA - ROQAF
21%
Poorly correlated
-0.68%
SKYE - ROQAF
21%
Poorly correlated
-7.09%
SNTI - ROQAF
6%
Poorly correlated
+0.61%
More

SNTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with PPBT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then PPBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
+0.61%
PPBT - SNTI
54%
Loosely correlated
N/A
TCRT - SNTI
47%
Loosely correlated
-14.04%
INBX - SNTI
41%
Loosely correlated
+2.33%
VERV - SNTI
34%
Loosely correlated
+26.38%
PTCT - SNTI
33%
Poorly correlated
+4.89%
More